YS Biopharma Co., Ltd. announced the results of its extraordinary general meeting held on February 16, 2024. The Company's shareholders voted against the following resolution: The following Directors be removed from office with immediate effect: Mr. Hui Shao; Mr. Bo Tan; Dr. Ajit Shetty; Dr. Viren Mehta; Mr. Shaojing Tong and Ms. Rachel Yu.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.89 USD | +6.59% | -12.75% | +74.17% |
28/05 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
24/05 | YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.17% | 17Cr | |
-1.62% | 9.09TCr | |
-1.05% | 3.9TCr | |
-11.20% | 3.35TCr | |
-20.75% | 1.45TCr | |
-6.35% | 1.32TCr | |
-11.42% | 1.17TCr | |
-47.67% | 1.06TCr | |
+5.62% | 923.36Cr | |
+102.03% | 770.73Cr |
- Stock Market
- Equities
- LSB Stock
- News LakeShore Biopharma Co., Ltd
- YS Biopharma Co., Ltd. Announces Board Resignations